Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | D(3) dopamine receptor | ||
Ligand | BDBM476757 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | 0.140±n/a nM | ||
Citation | Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent US10870660 Publication Date 12/22/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
D(3) dopamine receptor | |||
Name: | D(3) dopamine receptor | ||
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 | ||
Type: | n/a | ||
Mol. Mass.: | 44243.43 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM476757 | |||
n/a | |||
Name | BDBM476757 | ||
Synonyms: | US10870660, Compound III-019 | US11345716, Compound III-019 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H35F2N5O3 | ||
Mol. Mass. | 491.5739 | ||
SMILES | Cc1nc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OCC(C)(F)F)nc4CC3)CC2)no1 |r,wU:11.11,wD:8.7,(13.39,2.1,;11.85,2.1,;10.82,3.24,;9.41,2.61,;8.08,3.38,;6.75,2.61,;6.75,1.07,;5.41,3.38,;4.08,2.61,;2.74,3.38,;1.41,2.61,;1.41,1.07,;.08,.3,;-1.26,1.07,;-2.59,.3,;-2.48,-1.23,;-3.6,-2.28,;-5.13,-2.05,;-5.9,-3.38,;-7.44,-3.38,;-8.21,-2.05,;-9.75,-2.05,;-10.52,-.72,;-12.06,-.72,;-12.83,.62,;-12.06,-2.26,;-13.39,-1.49,;-7.44,-.72,;-5.9,-.72,;-5.33,.72,;-3.86,1.17,;2.74,.3,;4.08,1.07,;9.57,1.08,;11.08,.76,)| | ||
Structure |